Annual meeting highlighted discoveries in prostate cancer, epigenetic regulation, and immunotherapy, suggesting advancements in patient outcomes.
The 2025 Society of Academic Urologists (SAU) annual meeting was held during Jun 15-18, 2025, and showcased the latest discoveries in urologic oncology with a particular emphasis on prostate cancer biology, epigenetic regulation, immunotherapy, and novel therapeutic targets. Featuring an exceptional lineup of keynote speakers, scientific symposia, and interactive forums, the meeting provided a dynamic platform for the exchange of ideas among researchers, clinicians, and trainees dedicated to advancing urologic science and improving patient outcomes.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: